Director, Europe Patient Advocacy, Professional Relations, and Patient Engagement

At Genmab we are dedicated to building extranotordinary futures together by developing antibody products and groundbreaking knock-your-socks-off KYSO antibody medicines that change lives and the future of cancer treatment and serious diseases. We strive to create champion and maintain a global workplace where individuals unique contributions are valued and drive innovative solutions to meet the needs of our patients care partners families and employees.

Our people are compassionate candid and purposeful and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes our work is incredibly serious and impactful but we have big ambitions bring a ton of care to pursuing them and have a lot of fun while doing so.

Does this inspire you and feel like a fit Then we would love to have you join us!

Role

Location: Europe ( Switzerland) Scope: Europe (EU/EEA/UK/CH as applicable) Work model: Hybrid (per local site policy) Travel: Up to 30% (primarily within Europe)

Genmab is focused on the creation and development of innovative differentiated antibody products to improve the lives of people with cancer.

We are seeking a team-oriented results-driven professional committed to outstanding collaboration and passionate about strengthening the patient voice in Genmabs decision-making. The Director/Associate Director Patient Engagement & Professional Relations (Europe) will lead and advance patient and professional engagement activities across Europe ensuring the European patient voice is meaningfully represented in Genmabs strategy and decision-making while partnering closely with global colleagues and alliance partners.

Responsibilities

• European strategy & planning
  • Develop and execute a Europe-wide patient and professional organization engagement strategy aligned with Genmabs global objectives and adapted to regional and country differences.
  • Act as a strategic partner to cross-functional leaders to ensure patient engagement priorities are integrated across the product lifecycle.
• External stakeholder engagement (Europe)
  • Build and maintain trusted partnerships with European and country-level patient advocacy groups umbrella organizations and professional societies relevant to hematologic malignancies and solid tumors.
  • Represent Genmab in appropriate European forums and at major oncology congresses collaborating with Medical Commercial and Alliance teams.
• Health Technology Assessment

o Partner cross-functionally with Market Access/HEOR Medical Affairs Regulatory Value & Evidence and Commercial teams to ensure the European patient voice is appropriately incorporated into HTA strategy and submissions where relevant.

o Build and sustain relationships with European and country-level patient organizations to support ethical compliant and meaningful inclusion of patient perspectives in evidence generation and HTA-aligned activities (e.g. patient insights preference research PRO strategy qualitative research and engagement around value narratives).

o Help translate patient insights into HTA-relevant outputs (e.g. unmet need articulation treatment burden quality-of-life impacts caregiver impact and patient journey insights) and ensure internal teams can use them effectively and compliantly.

o Coordinate (as appropriate) patient input opportunities that may support HTA readiness (e.g. advisory boards structured interviews workshops) and ensure feedback loops back to participating organizations and internal stakeholders.

o Ensure all HTA-related patient engagement activities align with applicable European/local requirements EFPIA and national codes privacy requirements and Genmab policies.

• Bring the European patient voice into Genmab
  • Identify design and deliver innovative approaches to incorporate European patient insights into Genmab decision-makingespecially with Medical Affairs Clinical Development Regulatory Market Access/HEOR Marketing/Commercial and Alliance colleagues.
  • Translate patient insights into actionable recommendations and ensure feedback loops back to participating organizations and internal stakeholders.
• Governance compliance and privacy (Europe)
  • Ensure all activities align with applicable European and local requirements and industry codes (e.g. EFPIA and relevant national codes) and Genmab policies and procedures.
  • Partner with Legal Compliance Medical and Privacy stakeholders to define appropriate engagement models contracting transparency documentation and reporting.
• Patient advisory councils & insight forums
  • Oversee and manage internal patient advisory council activities supporting Europe including:
    • Defining objectives participant profiles agendas pre-reads and facilitation plans
    • Coordinating approvals and compliance documentation
    • Capturing outcomes through compliant minutes and follow-up reports
    • Tracking action items and ensuring patient input is reflected in cross-functional plans
• Sponsorships grants and congress engagement
  • Coordinate sponsorship and (where applicable) funding/grant processes with patient and professional organizations ensuring compliant documentation and governance.
  • Plan and support internal patient panels science days and meetings with patient and professional organizations at major European congresses.
• Operational leadership
  • Assist with budgets as assigned including forecasting and tracking spend against objectives.
  • Contribute to the development and alignment of patient engagement policies SOPs and playbooks across Europe.
  • Support other related tasks as assigned.

Requirements

• Advanced degree required (MBA MS PharmD PhD MD or equivalent).
• 10 years of experience including 6 years in patient engagement/advocacy stakeholder relations medical affairs public affairs market access or closely related roles in healthcare/life sciences.
• Strong understanding of European healthcare systems and policy topics impacting oncology patients (e.g. access reimbursement HTA RWE patient involvement frameworks) and the ability to navigate country-level differences.
• Language: Fluency in English required. Additional European languages are a strong advantage.
• Demonstrated success building and sustaining partnerships with patient and professional organizations across multiple European countries.
• Strong presentation and facilitation skills; experience running advisory boards and cross-functional sessions.
• Ability to travel up to 30% (including occasional overnight/weekend travel) primarily within Europe.

The Team Member Were Looking For (moved it from under responsibilities)

• An authentic innovative collaborative and engaging communicator who can build credibility with diverse European stakeholders and internal teams.
• Strong organizational skills with the ability to manage multiple projects across countries functions and timelines.
• Comfortable interacting with colleagues at all levels and representing Genmab externally.
• Excellent verbal and written communication; strong facilitation skills for advisory boards and workshops.
• A genuine passion for social impact and improving outcomes for people living with cancer.

About You

• You are genuinely passionate about our purpose

• You bring precision and excellence to all that you do

• You believe in our rooted-in-science approach to problem-solving

• You are a generous collaborator who can work in teams with a broad spectrum of backgrounds

• You take pride in enabling the best work of others on the team

• You can grapple with the unknown and be innovative

• You have experience working in a fast-growing dynamic company (or a strong desire to)

• You work hard and are not afraid to have a little fun while you do so!

About Genmab

Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years its hard-working innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational quantitative and data sciences resulting in a proprietary pipeline including bispecific T-cell engagers antibody-drug conjugates next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030 Genmabs vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO) antibody medicines.

Established in 1999 Genmab is headquartered in Copenhagen Denmark with international presence across North America Europe and Asia Pacific. For more information please visit and follow us on LinkedIn and X.

Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice ().

Please note that if you are applying for a position in the Netherlands Genmabs policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year if the employee performs well and if the business conditions do not change renewal for an indefinite term may be considered after the fixed-term employment contract.